Jon Snodgres - 08 Mar 2022 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
Chief Financial Officer
Signature
/s/ Kimberly Brown (Attorney in Fact)
Issuer symbol
RGEN
Transactions as of
08 Mar 2022
Net transactions value
+$172,242
Form type
4
Filing time
09 Mar 2022, 19:02:03 UTC
Previous filing
02 Mar 2022
Next filing
17 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Options Exercise $99,984 +2,952 +8.3% $33.87* 38,685 08 Mar 2022 Direct
transaction RGEN Common Stock Options Exercise $72,257 +1,214 +3.1% $59.52 39,899 08 Mar 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGEN Stock Option (Right to Buy) Options Exercise $0 +2,952 +27% $0.000000 13,707 08 Mar 2022 Common Stock 2,952 $33.87 Direct F1
transaction RGEN Stock Option (Right to Buy) Options Exercise $0 +1,214 +89% $0.000000 2,574 08 Mar 2022 Common Stock 1,214 $59.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is currently exercisable.